I Hate Dialysis Message Board
Dialysis Discussion => Dialysis: News Articles => Topic started by: okarol on March 12, 2011, 09:39:51 PM
-
Fresenius snaps up dialysis monitor assets
By Dave Price
Created 03/08/2011 - 17:30
March 8, 2011 by Dave Price
Fresenius Medical acquires the Crit-Line brand from Utah-based Hema Metrics for an undisclosed amount, in a deal that includes all assets related to blood monitoring systems and the Crit-Line sales force.
Fresenius Medical Care AG (NYSE:FMS [1]) shares are rebounding from earlier losses and were back to within 50 cents of even for today's session at $68.14 each, after the German medical device manufacturer announced plans to acquire the Crit-Line system from privately held Hema Metrics. Terms of the deal were not immediately available.
The Crit-Line III [2] is a non-invasive monitor designed to measure and manage the ratio of fluids and red blood cells in dialysis patients. The graphic display lists metrics such as blood volume changes over time as well as alphanumeric output of hematocrit and oxygen levels. The Crit-Line and associated products are 510(k)-cleared by the FDA and also carry the CE mark for European sales.
Fresenius, which last month moved to challenge NxStage Medical [3] in the home dialysis market, said Crit-Line will be a good fit with its existing line of hemodialysis machines and that the Hema Metrics sales organization will augment its position in the North American market.
http://massdevice.com/print/news/fresenius-snaps-dialysis-monitor-assets
-
Fresenius snaps up dialysis monitor assets
March 8, 2011 by Dave Price
Crit-Line brand from Utah-based Hema Metrics for an undisclosed amount
Hema Metrics is the company that one of our own forum member, The Lone IT from HM (http://ihatedialysis.com/forum/index.php?action=profile;u=47783), works for.